NMDA receptor agonists: relationships between structure and biological activity
Ebert, B.; Madsen, U.; Johansen, T.N.; Krogsgaard-Larsen, P.
Advances in Experimental Medicine and Biology 287: 483-487
1991
ISSN/ISBN: 0065-2598 PMID: 1836933 Document Number: 378290
Document emailed within 1 workday
Related Documents
Perez, M.; John, G.W. 1999: Structure-activity relationships and pharmacological profiles of new 5-HT(1) receptor agonists as antimigraine agents Current Opinion in Drug Discovery and Development 2(4): 304-310Piscopo, E.; Diurno, M.V.; Gagliardi, R.; Mazzoni, O.; de Francesco, F.M.; Parrilli, C. 1989: Structure-activity relationships of hydrazono derivatives of biological interest Bollettino della Societa Italiana di Biologia Sperimentale 65(4): 311-316
Kohli, J.D.; Weder, A.B.; Goldberg, L.I.; Ginos, J.Z. 1980: Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors Journal of Pharmacology and Experimental Therapeutics 213(2): 370-374
Rejholec, V.; Kuchar, M. 1980: Use of methods of differentiating between arrangements in chemical structure and biological activity relationships Ceskoslovenska Farmacie 29(8-9): 315-320
Kim, R.S.; LaBella, F.S.; Zunza, H.; Zunza, F.; Templeton, J.F. 1980: Progesterone derivatives that bind to the digitalis receptor: structure--activity relationships Molecular Pharmacology 18(3): 402-405
Pawlikowski, M.; Kunert-Radek, J. 1995: Failure of excitatory amino acids receptor agonists NMDA and quiscalate to affect the cell proliferation Polish Journal of Pharmacology 47(2): 185-187
Jóźwiak, L.; Łukawski, K.; Czuczwar, Sław.J.; Sieklucka-Dziuba, M. 2004: Competitive NMDA receptor antagonists and agonists: effects on spontaneous alternation in mice exposed to cerebral oligemia Polish Journal of Pharmacology 56(1): 59-66
Carbone, V.; Kim, H.; Huang, J.X.; Baker, M.A.; Ong, C.; Cooper, M.A.; Li, J.; Rockman, S.; Velkov, T. 2013: Molecular characterization of the receptor binding structure-activity relationships of influenza B virus hemagglutinin Acta Virologica 57(3): 313-332
Skuza, G. 2000: Combined treatment with NMDA antagonist, CGP 37849, and sigma receptor agonists, SA4503 or DTG, decreases the neuroleptic-induced catalepsy in rats Polish Journal of Pharmacology 52(4): 313-316
Krause, M.; Rouleau, A.; Stark, H.; Garbarg, M.; Schwartz, J.C.; Schunack, W. 1996: Structure-activity relationships of novel azomethine prodrugs of the histamine H3-receptor agonist (R)-alpha-methylhistamine: from alkylaryl to substituted diaryl derivatives Die Pharmazie 51(10): 720-726
Mager, H.; Barth, A. 1979: Problems involved in the specification and interpretation of quantitative structure-activity relationships. Part 1: a modified type of structure-activity equations Die Pharmazie 34(9): 557-559
Seiler, S.M.; Peluso, M.; Tuttle, J.G.; Pryor, K.; Klimas, C.; Matsueda, G.R.; Bernatowicz, M.S. 1996: Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists Molecular Pharmacology 49(1): 190-197
Wang, E.H.; Du, F.D.; Xiang, B.R. 1981: Molecular connectivity studies on quantitative structure-activity of drugs. II. Quantitative structure-activity relationships for leucomycins, lincomycins and clindamycins Yao Xue Xue Bao 16(2): 86-91
Dahlberg, E.; Thalén, A.; Brattsand, R.; Gustafsson, J.A.; Johansson, U.; Roempke, K.; Saartok, T. 1984: Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids Molecular Pharmacology 25(1): 70-78
Car, H.; Oksztel, R.; Nadlewska, A.; Wiśniewski, K. 2001: NMDA receptor antagonists change behavioral activity of rats treated with (S)-4CPG Polish Journal of Pharmacology 53(4): 331-339
Bickler, P.E. 1998: Reduction of NMDA receptor activity in cerebrocortex of turtles (Chrysemys picta) during 6 wk of anoxia American Journal of Physiology 275(1): R86-R91
Jönsson, N.A. 1972: Chemical structure and teratogenic properties. 3. a review of available data on structure-activity relationships and mechanism of action of thalidomide analogues Acta Pharmaceutica Suecica 9(6): 521-542
Altomare, C.; Carotti, A.; Cellamare, S.; Carrieri, A.; Ciabatti, R.; Malabarba, A. 1994: Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships Journal of Pharmacy and Pharmacology 46(12): 994-999
Fagart, J.; Pinon, G.M.; Rafestin-Oblin, M.E. 2004: Agonists and antagonists of mineralocorticoids. The relation between structure and activity Annales de Cardiologie et D'angeiologie 53(3): 154-157
Eriks, J.C.; van der Goot, H.; Timmerman, H. 1993: New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists Molecular Pharmacology 44(4): 886-894